PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $86,000 | – | 10,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management III, LLC | 722,890 | $911,000 | 0.53% |
GREAT POINT PARTNERS LLC | 3,500,000 | $4,410,000 | 0.44% |
NEA Management Company, LLC | 5,556,778 | $7,002,000 | 0.36% |
SECTORAL ASSET MANAGEMENT INC | 2,050,328 | $2,583,000 | 0.31% |
HARBOURVEST PARTNERS LLC | 440,627 | $555,000 | 0.20% |
VHCP Management II, LLC | 427,110 | $538,000 | 0.16% |
Endurant Capital Management LP | 130,600 | $165,000 | 0.06% |
ALGERT GLOBAL LLC | 64,300 | $81,000 | 0.05% |
Bain Capital Public Equity Management, LLC | 231,418 | $292,000 | 0.03% |
Kazazian Asset Management, LLC | 14,436 | $18,000 | 0.02% |